277 related articles for article (PubMed ID: 31576785)
1. Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.
Campbell LM; Fennema-Notestine C; Saloner R; Hussain M; Chen A; Franklin D; Umlauf A; Ellis RJ; Collier AC; Marra CM; Clifford DB; Gelman BB; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Heaton RK;
J Int Neuropsychol Soc; 2020 Feb; 26(2):147-162. PubMed ID: 31576785
[TBL] [Abstract][Full Text] [Related]
2. Effects of comorbidity burden and age on brain integrity in HIV.
Saloner R; Heaton RK; Campbell LM; Chen A; Franklin D; Ellis RJ; Collier AC; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Fennema-Notestine C;
AIDS; 2019 Jun; 33(7):1175-1185. PubMed ID: 30870195
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.
Kallianpur AR; Gittleman H; Letendre S; Ellis R; Barnholtz-Sloan JS; Bush WS; Heaton R; Samuels DC; Franklin DR; Rosario-Cookson D; Clifford DB; Collier AC; Gelman B; Marra CM; McArthur JC; McCutchan JA; Morgello S; Grant I; Simpson D; Connor JR; Hulgan T;
Mol Neurobiol; 2019 May; 56(5):3808-3818. PubMed ID: 30209774
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
Jia P; Zhao Z; Hulgan T; Bush WS; Samuels DC; Bloss CS; Heaton RK; Ellis RJ; Schork N; Marra CM; Collier AC; Clifford DB; Gelman BB; Sacktor N; Morgello S; Simpson DM; McCutchan JA; Barnholtz-Sloan JS; Franklin DR; Rosario D; Letendre SL; Grant I; Kallianpur AR;
Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):413-426. PubMed ID: 28447399
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
6. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
7. Should the Frascati criteria for HIV-associated neurocognitive disorders be used in children?
Bearden DR; Meyer AC
Neurology; 2016 Jul; 87(1):17-8. PubMed ID: 27206721
[No Abstract] [Full Text] [Related]
8. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
[TBL] [Abstract][Full Text] [Related]
9. Defining cognitive impairment in people-living-with-HIV: the POPPY study.
De Francesco D; Underwood J; Post FA; Vera JH; Williams I; Boffito M; Sachikonye M; Anderson J; Mallon PW; Winston A; Sabin CA;
BMC Infect Dis; 2016 Oct; 16(1):617. PubMed ID: 27793128
[TBL] [Abstract][Full Text] [Related]
10. Cardio-ankle vascular index of increased arterial wall stiffness is associated with neurocognitive impairment in well-controlled HIV.
Kaewpoowat Q; Rerkasem A; Rerkasem K; Robertson KR; Aita SL; Roth RM; Yasri S; Choovuthayakorn J; Ausayakhun S; Supparatpinyo K; Robbins NM
HIV Med; 2022 Jul; 23(6):599-610. PubMed ID: 34859556
[TBL] [Abstract][Full Text] [Related]
11. Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment.
Underwood J; De Francesco D; Leech R; Sabin CA; Winston A;
PLoS One; 2018; 13(4):e0194760. PubMed ID: 29641619
[TBL] [Abstract][Full Text] [Related]
12. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.
Blackstone K; Moore DJ; Franklin DR; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Ellis RJ; Atkinson JH; Grant I; Heaton RK
Clin Neuropsychol; 2012; 26(6):894-908. PubMed ID: 22708483
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
14. Elevation of brain ADC (apparent diffusion coefficient) in HIV-associated neurocognitive disorders and evolution after treatment: A pilot study.
Law-Ye B; de Truchis P; Peyrassou D; Force G; Carlier RY
J Neurol Sci; 2022 Nov; 442():120446. PubMed ID: 36265262
[TBL] [Abstract][Full Text] [Related]
15. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
[TBL] [Abstract][Full Text] [Related]
16. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
17. Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults.
Matchanova A; Woods SP; Kordovski VM
J Neurovirol; 2020 Apr; 26(2):155-167. PubMed ID: 31745823
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive impairment and gray matter volume reduction in HIV-infected patients.
Kato T; Yoshihara Y; Watanabe D; Fukumoto M; Wada K; Nakakura T; Kuriyama K; Shirasaka T; Murai T
J Neurovirol; 2020 Aug; 26(4):590-601. PubMed ID: 32572834
[TBL] [Abstract][Full Text] [Related]
19. Gray matter volumes discriminate cognitively impaired and unimpaired people with HIV.
Schantell M; Taylor BK; Lew BJ; O'Neill JL; May PE; Swindells S; Wilson TW
Neuroimage Clin; 2021; 31():102775. PubMed ID: 34375884
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
